HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Summary of the practice guideline 'Miscarriage' (second revision) from the Dutch College of General Practitioners (NHG)].

Abstract
The NHG practice guideline 'Miscarriage' provides guidelines for the diagnosis and management of pregnant women with vaginal bleeding during the period up to and including the 16th week after the first day of the last menstruation. The guideline has been revised on the basis of the developments over the last few years. The most important modifications are: In case of an imminent miscarriage, more consideration than before is given to the patient's preference with regard to ultrasonography, expectant management and curettage. The GP should therefore discuss the advantages and disadvantages of these options with the patient. A midwife was involved in the formulation of the new guideline. Referral from a GP to a midwife for transvaginal ultrasonography is offered as one of the possibilities. The paragraph on 'information' has been expanded on the basis of the results of a patient focus group.
AuthorsJ A M van Balen, S Flikweert, M Wieringa-de Waard, A de jonge, Tj Wiersma, A N Goudswaard
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 149 Issue 6 Pg. 295-8 (Feb 05 2005) ISSN: 0028-2162 [Print] Netherlands
Vernacular TitleSamenvatting van de standaard 'miskraam' (tweede herziening) van het nederlands huisartsen genootschap.
PMID15730036 (Publication Type: English Abstract, Guideline, Journal Article, Practice Guideline)
Topics
  • Abortion, Spontaneous (prevention & control, therapy)
  • Abortion, Threatened (diagnosis, prevention & control)
  • Adult
  • Female
  • Humans
  • Netherlands
  • Physicians, Family (standards)
  • Pregnancy
  • Pregnancy Trimester, First
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: